Merck Expands End-to-End Biodevelopment Centers in North America, China and Europe
MilliporeSigma | January 10, 2017
Merck, a leading science and technology company, today announced the expansion of its end-to-end biodevelopment centers to meet increasing customer demand for its turnkey portfolio of bioprocessing products, manufacturing capabilities and industry leading technological expertise.